The University of Oxford have posted a preprint looking at preliminary findings of the Oxford AstraZeneca vaccine and the B.1.1.7 ‘Kent’ … read more
We recently heard the interim high-level results from phase 3 clinical trials of the Oxford AstraZeneca COVID-19 vaccine in the … read more
Journalists from around the world were invited to join a media briefing webinar on the positive high-level results from an … read more
The Oxford vaccine have published data from the phase 2 trial of their COVID-19 vaccine candidate, the ChAdOx1 nCoV-19 vaccine. … read more
Early stage results from a phase 1/2 clinical trial of the University of Oxford’s vaccine candidate against SARS-CoV-2 have just … read more
A team of researchers have been working hard to develop a COVID-19 vaccine, and two weeks ago they opened their … read more
With numbers of cases of the novel coronavirus still increasing in China, cases now having been reported in at least … read more
In advance of the 2011/12 flu season, this Science Media Centre and Society for General Microbiology briefing involved five experts in various aspects of seasonal and pandemic influenza, who discussed topics including virology, pathology, vaccine development, public health and surveillance. read more